Philip Baker is a Professor and Pro-Vice-Chancellor for Medicine and Health Sciences at the University of East Anglia, affiliated with Norwich Medical School and the Metabolic Health research group. He previously served as Pro-Vice-Chancellor for Life Sciences and Dean of Medicine at the University of Leicester, demonstrating a strong leadership trajectory in academic medicine. His research focuses on maternal and fetal health, with particular emphasis on placental biology, preeclampsia, prenatal environmental exposures (including air pollution and metals), and neurodevelopmental outcomes. His work integrates clinical obstetrics with molecular and epidemiological approaches, often from an international perspective shaped by leadership roles in North America, Asia, and Australasia. Recent publications highlight ongoing contributions to understanding placental regulation of fetal growth, vasodilatory dysfunction in preeclampsia, and the impact of environmental factors on child development. These works reflect a sustained focus on perinatal medicine and developmental origins of health and disease. Fellow of the Academy of Medical Sciences Principal author of the G8 2010 position paper on 'Health of Women and Children' Baker has supervised over 40 PhD/MD theses and secured over £50 million in direct research funding, with institutional applications exceeding £100 million. His leadership roles have involved managing budgets up to £250 million annually and large research teams. He is actively involved in major research initiatives such as the CLIMB cohort study and the STRIDER trial. He is based at the Bob Champion Research & Education Building at UEA and maintains a high research output, with over 450 peer-reviewed articles and an H-index of approximately 98.







